Attorneys general around the country announced a multistate settlement in which Johnson & Johnson and its subsidiary Ethicon Inc. will pay roughly $116.9 million to resolve allegations of deceptive marketing of transvaginal surgical mesh devices.

Under the settlement, Johnson & Johnson has agreed to pay that total to 41 participating states and the District of Columbia, AGs said.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]